MINIMIZED PROTEINS

The design of bioactive small molecules for interaction at larger prot ein-protein interfaces remains a challenge. Recent progress towards mi nimizing proteins into significantly smaller polypeptides has been ach ieved via both rational design processes and selection from vast combi natorial libraries. Such 'mini-proteins' represent a potential interme diate step toward the development of drugs targeted to protein-protein interfaces.